INNOVATIVE EYEWEAR, INC. (LUCY) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | (m) | |
| Revenue | 3.41M USD | |
| Cost of products and services | (m) | |
| Research and development | 526.79K USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $3.41M | (m) | $526.79K | (m) | (m) |
| 2026-03-31 | (m) | $2.98M | (m) | $652.92K | (m) | (m) |
| 2025-12-31 | (m) | $2.66M | (m) | $725.39K | (m) | (m) |
| 2025-09-30 | (m) | $2.39M | (m) | $823.70K | (m) | (m) |
| 2025-06-30 | (m) | $1.98M | (m) | $825.08K | (m) | (m) |
| 2025-03-31 | (m) | $1.71M | (m) | $813.66K | (m) | (m) |
| 2024-12-31 | (m) | $1.64M | (m) | $819.39K | (m) | (m) |
| 2024-09-30 | (m) | $1.56M | (m) | $725.31K | (m) | (m) |
| 2024-06-30 | (m) | $1.53M | (m) | $786.64K | (m) | (m) |
| 2024-03-31 | (m) | $1.39M | (m) | $727.32K | (m) | (m) |
| 2023-12-31 | (m) | $1.15M | (m) | $662.18K | (m) | (m) |
| 2023-09-30 | (m) | $603.79K | (m) | $672.98K | (m) | (m) |
| 2023-06-30 | (m) | $533.88K | (m) | $784.97K | (m) | (m) |
| 2023-03-31 | (m) | $568.69K | (m) | $640.05K | (m) | (m) |
| 2022-12-31 | (m) | $659.79K | (m) | $524.69K | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $690.67K | (m) | $86.26K | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |